Home/Filings/4/0001127602-24-017329
4//SEC Filing

Lee Sung 4

Accession 0001127602-24-017329

CIK 0001061983other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 5:07 PM ET

Size

7.2 KB

Accession

0001127602-24-017329

Insider Transaction Report

Form 4
Period: 2024-05-31
Lee Sung
EVP, Chief Financial Officer
Transactions
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2024-05-31+53,41753,417 total
    Exercise: $48.51From: 2025-06-02Exp: 2034-05-30Common Stock (53,417 underlying)
  • Award

    Common Stock

    2024-05-31+34,68434,684 total
Footnotes (2)
  • [F1]Comprised of restricted stock units convertible into shares of common stock on a 1-for-1 basis and vesting as follows: 40% on the 1-year anniversary of the grant date, an additional 40% on the 2-year anniversary of the grant date, and the remaining 20% on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment.
  • [F2]Comprised of non-statutory stock options to purchase shares of common stock and vesting as follows: 25% on the 1-year anniversary of the grant date and the remaining 75% vesting in equal monthly installments over the subsequent 36 months from the 1-year anniversary of the grant date, in each case subject to continued employment.

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeother

Related Parties

1
  • filerCIK 0001793200

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:07 PM ET
Size
7.2 KB